Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine vs Lidocaine in ETT cuff for post-operative sore throat
NCT03563963Completed
- Sponsor
- University of Saskatchewan
- Start
- Aug 2018
- Primary completion
- Sep 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of ropivacaine in pharyngitis, sponsored by University of Saskatchewan. Primary endpoint: Post-operative sore throat. Started Aug 2018; status: completed.
02
Drugs
ropivacaine
03
Conditions
pharyngitis
Beyond the preview
Go deeper on NCT03563963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03563963.